Please login to the form below

Not currently logged in
Email:
Password:

Infographic: Pharma investment in Indonesia

Pharma deals in the region since the introduction of Decree 1010 to force companies to manufacture products locally

In 2008, the government in Indonesia released Decree 1010, meaning all foreign pharma companies working in the country had to manufacture drugs locally or form a partnership with a local manufacturer in order to register their own medicines.

This infographic details all the agreements formed by pharma companies in the region in the five years since Decree 1010 was published.

The affected pharma companies are MSD, Sanofi, Servier, AstraZeneca, Novo Nordisk, Lilly, Janssen- Cilag, Astellas, Wyeth, Roche and PT Orshonovo.

Read the accompanying article on pharma investment in Indonesia


2013: Five years after Decree 1010 - what has changed in Indonesia?
(Click on the image for a larger version)

Indonesia infographic

The graphic was compiled by Deallus Consulting and designed by PMGroup

23rd July 2013

The graphic was compiled by Deallus Consulting and designed by PMGroup

23rd July 2013

From: Sales, Regulatory, Healthcare

Share

Tags


Career advice

No results were found

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Infographics